These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

22 related articles for article (PubMed ID: 11874267)

  • 1. [Commentary to the article: Di Mario C, Dudek D, Piscione F, et al.; CARESS-in-AMI (Combined Abciximab RE-teplase Stent Study in Acute Myocardial Infarction) Investigators. Immediate angioplasty versus standard therapy with rescue angioplasty after thrombolysis in the Combined Abciximab REteplase Stent Study in Acute Myocardial Infarction (CARESS-in-AMI): an open, prospective, randomised, multicentre trial. Lancet 2008; 371: 559-68].
    Sosnowski C
    Kardiol Pol; 2008 Apr; 66(4):461-4; discussion 465-6. PubMed ID: 18634182
    [No Abstract]   [Full Text] [Related]  

  • 2. Life threatening massive pulmonary embolism treated with reteplase: a case report.
    Theron C; Laidlow DC
    Crit Care Resusc; 2000 Dec; 2(4):278-81. PubMed ID: 16597314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tenecteplase plus enoxaparin or abciximab was better than tenecteplase plus unfractionated heparin for acute MI.
    Borzak S
    ACP J Club; 2002; 136(2):42-3. PubMed ID: 11874268
    [No Abstract]   [Full Text] [Related]  

  • 4. Targeting the use of platelet IIb/IIIa inhibitors: treatment of acute myocardial infarction.
    Lincoff AM
    Rev Cardiovasc Med; 2002; 3 Suppl 1():S13-9. PubMed ID: 12439432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of major bleeding on 30-day mortality and clinical outcomes in patients with acute coronary syndromes: an analysis from the ACUITY Trial.
    Manoukian SV; Feit F; Mehran R; Voeltz MD; Ebrahimi R; Hamon M; Dangas GD; Lincoff AM; White HD; Moses JW; King SB; Ohman EM; Stone GW
    J Am Coll Cardiol; 2007 Mar; 49(12):1362-8. PubMed ID: 17394970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reteplase plus abciximab and reteplase alone led to similar 30-day mortality rates in acute MI.
    Borzak S
    ACP J Club; 2002; 136(2):42-3. PubMed ID: 11874267
    [No Abstract]   [Full Text] [Related]  

  • 7. [Combination therapy for acute myocardial infarction with glycoprotein IIb/IIIa inhibitors and fibrinolysis].
    Ottani F; Bresciani B; La Vecchia L; Favero L; Fontanelli A; Galvani M
    Ital Heart J Suppl; 2002 May; 3(5):544-54. PubMed ID: 12064194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reteplase was not better than alteplase in reducing 30-day mortality among patients with acute MI.
    Cannon CP
    Evid Based Cardiovasc Med; 1998 Mar; 2(1):16-7. PubMed ID: 16379780
    [No Abstract]   [Full Text] [Related]  

  • 9. [Combination therapy for acute myocardial infarction with glycoprotein IIb/IIIa inhibitors and fibrinolysis].
    Vandoni P; Poli A; Fetiveau R; Cafiero F; D'Urbano M; De Servi S
    Ital Heart J Suppl; 2002 May; 3(5):539-43. PubMed ID: 12064193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Facilitated angioplasty with combo therapy among patients with ST-segment elevation myocardial infarction: a meta-analysis of randomized trials.
    De Luca G; Marino P
    Am J Emerg Med; 2009 Jul; 27(6):683-90. PubMed ID: 19751625
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.